Log In
BCIQ
Print this Print this
 

Actifuse

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionCalcium phosphate bone void filler containing 0.8% by weight silicon
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBone repair
Indication DetailsTreat degenerative lumbar spine disease; Use as a bone void filler in orthopedic applications where gaps and voids that are not intrinsic to the stability of the bone structure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$330.0M

$240.0M

$90.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/12/2010

$330.0M

$240.0M

$90.0M

Get a free BioCentury trial today